Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayden Storts

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Research Communications|October 27, 2023
SIX4 Controls Anti-PD-1 Efficacy by Regulating STING ExpressionBeiyuan Liang, Evan H Zhang, Zhen Ye, et al.
Frontiers in Oncology|October 29, 2024
Antagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapyBeiyuan Liang, Xuanxuan Xing, Hayden Storts, et al.
Molecular Cancer Therapeutics|October 9, 2024
Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal CancerBeiyuan Liang, Misbah Khan, Hayden Storts, et al.
Cancer Letters|April 5, 2026
Coordinated Post-Transcriptional Regulation facilitates PD-L1 protein production and tumor immune suppressionRonghao Chen, Swetha Rajasekaran, Xuanxuan Xing, et al.
Thyroid : Official Journal of the American Thyroid Association|January 27, 2025
Proteomic Profiling of Medullary Thyroid Cancer Identifies CAPN1 as a Key Regulator of NF1 and RET Fueled GrowthEshan Khan, Hannah Hylton, Neel Rajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical TrialChunjie Li, Anne M Noonan, John Hays, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Research Communications|October 27, 2023
SIX4 Controls Anti-PD-1 Efficacy by Regulating STING ExpressionBeiyuan Liang, Evan H Zhang, Zhen Ye, et al.
Frontiers in Oncology|October 29, 2024
Antagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapyBeiyuan Liang, Xuanxuan Xing, Hayden Storts, et al.
Molecular Cancer Therapeutics|October 9, 2024
Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal CancerBeiyuan Liang, Misbah Khan, Hayden Storts, et al.
Cancer Letters|April 5, 2026
Coordinated Post-Transcriptional Regulation facilitates PD-L1 protein production and tumor immune suppressionRonghao Chen, Swetha Rajasekaran, Xuanxuan Xing, et al.
Thyroid : Official Journal of the American Thyroid Association|January 27, 2025
Proteomic Profiling of Medullary Thyroid Cancer Identifies CAPN1 as a Key Regulator of NF1 and RET Fueled GrowthEshan Khan, Hannah Hylton, Neel Rajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical TrialChunjie Li, Anne M Noonan, John Hays, et al.
Pageof 1